Quality of Life — Intestinal Permeability, Nutritional Status and Quality of Life in Celiac Disease
Citation(s)
Ajamian M, Steer D, Rosella G, Gibson PR Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seems. PLoS One. 2019 Jan 14;14(1):e0210728. doi: 10.1371/journal.pone.0210728. eCollection 2019.
Aksan A, Mercanligil SM, Häuser W, Karaismailoglu E Validation of the Turkish version of the Celiac Disease Questionnaire (CDQ). Health Qual Life Outcomes. 2015 Jun 19;13:82. doi: 10.1186/s12955-015-0272-y.
Bai JC, Ciacci C World Gastroenterology Organisation Global Guidelines: Celiac Disease February 2017. J Clin Gastroenterol. 2017 Oct;51(9):755-768. doi: 10.1097/MCG.0000000000000919. Erratum in: J Clin Gastroenterol. 2019 Apr;53(4):313.
Duerksen DR, Wilhelm-Boyles C, Parry DM Intestinal permeability in long-term follow-up of patients with celiac disease on a gluten-free diet. Dig Dis Sci. 2005 Apr;50(4):785-90.
Duerksen DR, Wilhelm-Boyles C, Veitch R, Kryszak D, Parry DM A comparison of antibody testing, permeability testing, and zonulin levels with small-bowel biopsy in celiac disease patients on a gluten-free diet. Dig Dis Sci. 2010 Apr;55(4):1026-31. doi: 10
Fasano A Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. Clin Gastroenterol Hepatol. 2012 Oct;10(10):1096-100. doi: 10.1016/j.cgh.2012.08.012. Epub 2012 Aug 16. Review.
Fasano A Intestinal zonulin: open sesame! Gut. 2001 Aug;49(2):159-62.
Fasano A Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall. Am J Pathol. 2008 Nov;173(5):1243-52. doi: 10.2353/ajpath.2008.080192. Epub 2008 Oct 2.
Hall NJ, Rubin G, Charnock A Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther. 2009 Aug 15;30(4):315-30. doi: 10.1111/j.1365-2036.2009.04053.x. Epub 2009 May 26. Review.
Häuser W, Gold J, Stallmach A, Caspary WF, Stein J Development and validation of the Celiac Disease Questionnaire (CDQ), a disease-specific health-related quality of life measure for adult patients with celiac disease. J Clin Gastroenterol. 2007 Feb;41(2
Miranda J, Lasa A, Bustamante MA, Churruca I, Simon E Nutritional differences between a gluten-free diet and a diet containing equivalent products with gluten. Plant Foods Hum Nutr. 2014 Jun;69(2):182-7. doi: 10.1007/s11130-014-0410-4. Erratum in: Plant
Paganizza S, Zanotti R, D'Odorico A, Scapolo P, Canova C Is Adherence to a Gluten-Free Diet by Adult Patients With Celiac Disease Influenced by Their Knowledge of the Gluten Content of Foods? Gastroenterol Nurs. 2019 Jan/Feb;42(1):55-64. doi: 10.1097/SGA
Schumann M, Siegmund B, Schulzke JD, Fromm M Celiac Disease: Role of the Epithelial Barrier. Cell Mol Gastroenterol Hepatol. 2017 Jan 14;3(2):150-162. doi: 10.1016/j.jcmgh.2016.12.006. eCollection 2017 Mar. Review.
Serin, Y , & Akbulut, G. Nutritional Status and Health-Related Quality of Life in Adlt Patients With Celiac Disease. CBU International Conference Proceedings 2018; 6: 952-959. https://doi.org/10.12955/cbup.v6.1277
Taetzsch A, Das SK, Brown C, Krauss A, Silver RE, Roberts SB Are Gluten-Free Diets More Nutritious? An Evaluation of Self-Selected and Recommended Gluten-Free and Gluten-Containing Dietary Patterns. Nutrients. 2018 Dec 3;10(12). pii: E1881. doi: 10.3390/
Theethira TG, Dennis M, Leffler DA Nutritional consequences of celiac disease and the gluten-free diet. Expert Rev Gastroenterol Hepatol. 2014 Feb;8(2):123-9. doi: 10.1586/17474124.2014.876360.
Vici G, Belli L, Biondi M, Polzonetti V Gluten free diet and nutrient deficiencies: A review. Clin Nutr. 2016 Dec;35(6):1236-1241. doi: 10.1016/j.clnu.2016.05.002. Epub 2016 May 7. Review.
Vojdani A, Vojdani E, Kharrazian D Fluctuation of zonulin levels in blood vs stability of antibodies. World J Gastroenterol. 2017 Aug 21;23(31):5669-5679. doi: 10.3748/wjg.v23.i31.5669.
The Investigation of Nutritional Status, Intestinal Permeability and Quality of Life in People With Celiac Disease
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
